The FDA has approved a new multiple myeloma treatment developed by Bristol Myers Squibb. This approval marks the introduction of a novel drug class, potentially impacting the pharmaceutical market.
FDA Approves Bristol Myers Squibb Multiple Myeloma Treatment
pharmaceuticalsdrug approvalbiotechBristol Myers Squibb
